http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0416801-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2004-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9d8a42c42ae4d717783400f1f65cf0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283c281e23aea15f0ef7c70ca4a65730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c029585627aebbb88f5e70af0d7fe3ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1454fc74b644247baeb1914f97a5f577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b10869e66e11446eab32e8dddfa9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80039df77c8f23c166dab374d6ce5c67
publicationDate 2007-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0416801-A
titleOfInvention 1h-imidazoquinoline derivatives as protein synase inhibitors
abstract "1H-IMIDAZOQUINOLINE DERIVATIVES AS PROTEIN SYNASE INHIBITORS". The invention relates to imidazoquinolines of formula (I) for use in the treatment of protein kinase dependent diseases; pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease; novel imidazoquinolines; and a process for the preparation of novel imidazoquinolines.
priorityDate 2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422062140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12954996

Total number of triples: 31.